Clinical Trials List
Protocol NumberTPX-0005-01
Active
2018-05-01 - 2025-06-30
Phase I/II
Terminated2
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- Shang-Yin Wu 無
- 劉奕廷 無
- Wen-Pin Su 無
- 趙盈瑞 無
- Wu-Chou Su 無
- Yu-Min Yeh 無
- 沈廷盛 無
- Wei-Pang Chung 無
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Jih-Hsiang Lee 無
- 徐偉勛 無
- 楊景堯 無
- 吳尚俊 無
- JIN-YUAN SHIH 無
- 蔡子修 無
- Chong-Jen Yu 無
- Chia-Chi Lin 無
- 陳冠宇 無
- 廖斌志 無
- CHAO-CHI HO CHAO-CHI HO 無
- YEN-TING LIN 無
- 許嘉林 無
- 廖唯昱 無
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
13 participants
-
Global
320 participants
